Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues? …
Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research. These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry. Nearly all of the phase 1 units across the United States …
To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively. This is true for nearly all therapeutic indications and all phases of clinical trials research. Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue. The global research subject database registry VCT data over the …
Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …
Duplicate subjects and preventable protocol violations can easily be prevented up-front at the time of screening using the global research subject database registry Verified Clinical Trials (VCT). The protections continue for the entire duration fo the study including the specific washout criteria. VCT has data that routinely demonstrates double digit preventable protocol violations. Professional research …
The global research subject duplicate enrollment prevention solution Verified Clinical Trials (VCT) and Foundry Health’s eSource and phase I automation platform ClinSpark are now electronically connected. The integration greatly simplifies the process for site users to check for duplicate subject enrollments and several other protocol violations. Verified Clinical Trials (VCT) and Foundry Health’s eSource and …
Great article by John Carlos Diaz on the issue of hashtag#professionalresearchsubjects and hashtag#duplicatesubjects https://lnkd.in/eJrFDDF. Use of the Verified Clinical Trials (VCT) prevents this issue at the time of screening and protects throughout the entire study. Easy to implement and cost-effective. Contact VCT at info@verifiedclinicaltrials.com or call +1.516.998.7499
Verified Clinical Trials & Research Centers of America partner to stop duplicate enrollment in South Florida We are grateful for this innovative resource and the real-time responses that have helped us avoid duplicate enrollment in our clinical trials. We are truly impressed with the staff at VCT and their readin.ess to help at every …
Celerion & Verified Clinical Trials Prevent Duplicate Enrollment In Clinical Trials Celerion and Verified Clinical Trials share the same vision of applying scientific expertise and advanced technology to ensure the safety of our participants and maintain data integrity… GARDEN CITY, NEW YORK (PRWEB) MARCH 14, 2017 Celerion was the first early stage contract research organization (CRO) to …
